Viewing StudyNCT05737706

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 6:39 PM
Last Modification Date: 2024-10-26 @ 2:52 PM
Study NCT ID: NCT05737706
Status: RECRUITING
Last Update Posted: 2024-06-21
First Post: 2023-02-10
Brief Title: Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation
Sponsor: Mirati Therapeutics Inc
Organization: Mirati Therapeutics Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Solid Tumor
Advanced Solid Tumor
Non-small Cell Lung Cancer
Colo-rectal Cancer
Pancreatic Adenocarcinoma
Keywords:
Name View
Pancreatic Adenocarcinoma View
Non-Small Cell Lung Cancer View
NSCLC View
colorectal cancer View
CRC View
PDAC View
KRAS View
G12D View
Solid Tumor View
Advanced Solid Tumor View
Malignant View
Pancreatic Cancer View